Oppenheimer Asset Management Inc. Repligen Corp Transaction History

Oppenheimer Asset Management Inc.

$6.65 Billion
Q1 2024

A detailed history of Oppenheimer Asset Management Inc. transactions in Repligen Corp stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 16,791 shares of RGEN stock, worth $2.02 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

16,791

Previous 17,484 3.96%

Holding current value

$2.02 Million

Previous $3.14 Million 1.75%

% of portfolio

0.05%

Previous 0.04%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$170.78 - $208.42 $118,350 - $144,435	-693 Reduced 3.96%	16,791 $3.09 Million
Q4 2023 Feb 13, 2024	SELL	$114.17 - $185.35 $49,663 - $80,627	-435 Reduced 2.43%	17,484 $3.14 Million
Q3 2023 Nov 07, 2023	BUY	$138.78 - $176.51 $231,068 - $293,889	1,665 Added 10.24%	17,919 $2.85 Million
Q2 2023 Aug 02, 2023	BUY	$138.42 - $180.31 $1.72 Million - $2.25 Million	12,453 Added 327.62%	16,254 $2.3 Million
Q1 2023 May 10, 2023	SELL	$154.26 - $198.1 $308 - $396	-2 Reduced 0.05%	3,801 $639,000

Q4 2022 Feb 06, 2023	SELL	$162.42 - $220.56 $29,235 - $39,700	-180 Reduced 4.52%	3,803 $643,000
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $92,562 - $147,833	-577 Reduced 12.65%	3,983 $745,000
Q2 2022 Aug 08, 2022	SELL	$140.68 - $188.02 $2.73 Million - $3.65 Million	-19,394 Reduced 80.96%	4,560 $741,000
Q1 2022 May 12, 2022	BUY	$161.19 - $257.96 $590,761 - $945,423	3,665 Added 18.06%	23,954 $4.51 Million
Q4 2021 Feb 02, 2022	SELL	$247.59 - $304.47 $148,058 - $182,073	-598 Reduced 2.86%	20,289 $5.37 Million
Q3 2021 Nov 12, 2021	BUY	$194.77 - $324.21 $3.3 Million - $5.5 Million	16,951 Added 430.67%	20,887 $6.04 Million
Q2 2021 Aug 03, 2021	BUY	$165.87 - $220.95 $1,492 - $1,988	9 Added 0.23%	3,936 $786,000
Q1 2021 May 17, 2021	BUY	$180.37 - $226.26 $14,790 - $18,553	82 Added 2.13%	3,927 $763,000
Q4 2020 Feb 11, 2021	BUY	$148.08 - $206.57 $24,137 - $33,670	163 Added 4.43%	3,845 $737,000
Q3 2020 Nov 13, 2020	BUY	$122.51 - $158.27 $25,114 - $32,445	205 Added 5.9%	3,682 $543,000
Q2 2020 Aug 11, 2020	BUY	$94.33 - $140.48 $75,275 - $112,103	798 Added 29.79%	3,477 $430,000
Q1 2020 May 08, 2020	BUY	$84.96 - $109.14 $50,721 - $65,156	597 Added 28.67%	2,679 $258,000
Q4 2019 Feb 07, 2020	SELL	$73.84 - $93.08 $6,128 - $7,725	-83 Reduced 3.83%	2,082 $193,000
Q3 2019 Oct 31, 2019	SELL	$76.65 - $95.51 $4,292 - $5,348	-56 Reduced 2.52%	2,165 $166,000
Q2 2019 Aug 09, 2019	SELL	$54.2 - $85.95 $8,888 - $14,095	-164 Reduced 6.88%	2,221 $190,000
Q1 2019 Apr 24, 2019	BUY	$49.45 - $62.8 $14,439 - $18,337	292 Added 13.95%	2,385 $141,000
Q4 2018 Jan 30, 2019	BUY	$48.26 - $68.88 $101,008 - $144,165	2,093 New	2,093 $110,000
Q4 2017 Feb 07, 2018	SELL	$32.53 - $38.92 $95,703 - $114,502	-2,942 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$36.98 - $46.06 $108,795 - $135,508	2,942	2,942 $113,000

Others Institutions Holding RGEN

# of Institutions

522

Shares Held

53.2M

Call Options Held

1.05M

Put Options Held

228K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.67B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Account

Oppenheimer Asset Management Inc. Repligen Corp Transaction History